Kaminska E, Adrjanowicz K, Zakowiecki D, Milanowski B, Tarnacka M, Hawelek L, Dulski M, Pilch J, Smolka W, Kaczmarczyk-Sedlak I, Kaminski K
Medical University of Silesia in Katowice, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Department of Pharmacognosy and Phytochemistry, ul. Jagiellonska 4, 41-200, Sosnowiec, Poland,
Pharm Res. 2014 Oct;31(10):2887-903. doi: 10.1007/s11095-014-1385-4. Epub 2014 May 15.
To demonstrate a very effective and easy way of stabilization of amorphous indomethacin (IMC) by preparing binary mixtures with octaacetylmaltose (acMAL). In order to understand the origin of increased stability of amorphous system inter- and intramolecular interactions between IMC and acMAL were studied.
The amorphous IMC, acMAL and binary mixtures (IMC-acMAL) with different weight ratios were analyzed by using Dielectric Spectroscopy (DS), Differential Scanning Calorimetry (DSC), Raman Spectroscopy, X-ray Diffraction (XRD), Infrared Spectroscopy (FTIR) and Quantitative Structure-Activity Relationship (QSAR).
Our studies have revealed that indomethacin mixed with acetylated saccharide forms homogeneous mixture. Interestingly, even a small amount of modified maltose prevents from recrystallization of amorphous indomethacin. FTIR measurements and QSAR calculations have shown that octaacetylmaltose significantly affects the concentration of indomethacin dimers. Moreover, with increasing the amount of acMAL in the amorphous solid dispersion molecular interactions between matrix and API become more dominant than IMC-IMC ones. Structural investigations with the use of X-ray diffraction technique have demonstrated that binary mixture of indomethacin with acMAL does not recrystallize upon storage at room temperature for more than 1.5 year. Finally, it was shown that acMAL can be used to improve solubility of IMC.
Acetylated derivative of maltose might be very effective agent to improve physical stability of amorphous indomethacin as well as to enhance its solubility. Intermolecular interactions between modified carbohydrate and IMC are likely to be responsible for increased stability effect in the glassy state.
通过制备与八乙酰麦芽糖(acMAL)的二元混合物,展示一种非常有效且简便的非晶态吲哚美辛(IMC)稳定化方法。为了理解非晶态体系稳定性提高的根源,研究了IMC与acMAL之间的分子间和分子内相互作用。
使用介电谱(DS)、差示扫描量热法(DSC)、拉曼光谱、X射线衍射(XRD)、红外光谱(FTIR)和定量构效关系(QSAR)分析非晶态IMC、acMAL以及不同重量比的二元混合物(IMC-acMAL)。
我们的研究表明,吲哚美辛与乙酰化糖类混合形成均匀混合物。有趣的是,即使少量的改性麦芽糖也能防止非晶态吲哚美辛重结晶。FTIR测量和QSAR计算表明,八乙酰麦芽糖显著影响吲哚美辛二聚体的浓度。此外,随着非晶态固体分散体中acMAL含量的增加,基质与活性药物成分之间的分子相互作用比IMC-IMC之间的相互作用更为显著。使用X射线衍射技术进行的结构研究表明,吲哚美辛与acMAL的二元混合物在室温下储存超过1.5年不会重结晶。最后,结果表明acMAL可用于提高IMC的溶解度。
麦芽糖的乙酰化衍生物可能是提高非晶态吲哚美辛物理稳定性以及增强其溶解度的非常有效的试剂。改性碳水化合物与IMC之间的分子间相互作用可能是玻璃态稳定性提高的原因。